Cargando…

Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TT(2)R(2) score

OBJECTIVES: This study aimed to investigate the efficacy and safety outcomes of patients with atrial fibrillation (AF) compared between those taking warfarin and non-vitamin K antagonist oral anticoagulants (NOACs) based on SAMe-TT(2)R(2) score. METHODS: AF patients using warfarin or NOACs were enro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Methavigul, Komsing, Yindeengam, Ahthit, Krittayaphong, Rungroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869584/ https://www.ncbi.nlm.nih.gov/pubmed/36690928 http://dx.doi.org/10.1186/s12872-023-03053-w

Ejemplares similares

Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Safety and efficacy of non–vitamin K antagonist oral anticoagulants compared with well-controlled warfarin in Thai patients with atrial fibrillation
por: Yamkasikorn, Janekij, et al.
Publicado: (2022)

Efficacy of R(2)CHA(2)DS(2)-VA score for predicting thromboembolism in Thai patients with non-valvular atrial fibrillation
por: Methavigul, Komsing, et al.
Publicado: (2021)

Use of simplified HAS‐BLED score in patients with atrial fibrillation receiving warfarin
por: Methavigul, Komsing, et al.
Publicado: (2019)

Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study
por: Krittayaphong, Rungroj, et al.
Publicado: (2018)

Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry
por: Winijkul, Arjbordin, et al.
Publicado: (2021)

Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL‐AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

Revised HAS‐BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants
por: Methavigul, Komsing
Publicado: (2022)

Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin
por: Luengsupabul, Sirote, et al.
Publicado: (2020)

Impact of anemia on clinical outcomes of patients with atrial fibrillation: The COOL‐AF registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study
por: Krittayaphong, Rungroj, et al.
Publicado: (2016)

The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Low Body Weight Increases the Risk of Ischemic Stroke and Major Bleeding in Atrial Fibrillation: The COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2020)

Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand
por: Krittayaphong, Rungroj, et al.
Publicado: (2020)

Myocardial Extracellular Volume Fraction and T1 Mapping by Cardiac Magnetic Resonance Compared Between Patients With and Without Type 2 Diabetes, and the Effect of ECV and T2D on Cardiovascular Outcomes
por: Laohabut, Issarayus, et al.
Publicado: (2021)

Heart failure mortality compared between elderly and non-elderly Thai patients
por: Krittayaphong, Rungroj, et al.
Publicado: (2018)

The SAMe-TT(2)R(2) Score Predicts Warfarin Control in an Australian Population with Atrial Fibrillation
por: Bernaitis, Nijole, et al.
Publicado: (2019)

History of major bleeding predicts risk of clinical outcome of patients with atrial fibrillation: results from the COOL-AF registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2020)

Extracellular volume and left ventricular hypertrophy by cardiac magnetic resonance are independent predictors of cardiovascular outcome in obesity
por: Lertlaksameewilai, Panuwat, et al.
Publicado: (2022)

Safety and clinical impact of adenosine stress perfusion cardiac magnetic resonance in Asian patients with known or suspected coronary artery disease
por: Kaolawanich, Yodying, et al.
Publicado: (2023)

Use of the SAMe-TT(2)R(2) Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence
por: Chan, Pak Hei, et al.
Publicado: (2016)

Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT(2)R(2) score-guided strategy in anticoagulant-naïve Thai patients with atrial fibrillation (TREATS-AF): a study protocol
por: Phrommintikul, Arintaya, et al.
Publicado: (2021)

Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
por: Friberg, Leif, et al.
Publicado: (2017)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
por: Nielsen, Peter Brønnum, et al.
Publicado: (2019)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
Publicado: (2020)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
por: Huang, Huei‐Kai, et al.
Publicado: (2020)

Should we shift warfarin to non-vitamin K antagonist oral anticoagulants for patients with atrial fibrillation staying well on warfarin for years?
por: Chao, T, et al.
Publicado: (2023)

Effect of SAMe-TT(2)R(2) score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin
por: Elewa, Hazem, et al.
Publicado: (2020)

Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
por: Lee, Hsin‐Fu, et al.
Publicado: (2019)

Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?
por: Hammwöhner, Matthias, et al.
Publicado: (2020)

Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation
por: Choi, Seong Huan, et al.
Publicado: (2022)

Real-world comparison of non-vitamin K antagonist oral anticoagulants and warfarin in Asian octogenarian patients with atrial fibrillation
por: Kwon, Chang Hee, et al.
Publicado: (2016)

Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Meta-analysis of the efficacy and safety of non-vitamin K antagonist oral anticoagulants with warfarin in Latin American patients with atrial fibrillation
por: Su, Zhiyu, et al.
Publicado: (2020)

Left Atrial Diameter in the Prediction of Thromboembolic Event and Death in Atrial Fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta‐Analysis
por: Deng, Yuqing, et al.
Publicado: (2019)

Non-vitamin K antagonist oral anticoagulants versus warfarin for cardioversion of atrial fibrillation in clinical practice: A single-center experience
por: Shibata, Naoki, et al.
Publicado: (2017)

Real‐life experience with non‐vitamin K antagonist oral anticoagulants versus warfarin in patients undergoing elective cardioversion of atrial fibrillation
por: Itäinen‐Strömberg, Saga, et al.
Publicado: (2020)

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study
por: Halvorsen, Sigrun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7bhu2tvbiednhct27h7ct08sdc